U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H7NO
Molecular Weight 109.1259
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NICOTINYL ALCOHOL

SMILES

OCC1=CN=CC=C1

InChI

InChIKey=MVQVNTPHUGQQHK-UHFFFAOYSA-N
InChI=1S/C6H7NO/c8-5-6-2-1-3-7-4-6/h1-4,8H,5H2

HIDE SMILES / InChI
Nicotinyl alcohol is a direct-acting vasolidator, that may decrease the blood pressure and it is a cholesterol-lowering agent. Nicotinyl alcohol as a tartrate salt led to the efficiency improvements in patients with intermittent claudication. In addition, nicotinyl alcohol alone or associated with other drugs was studied in the treatment of radicular syndromes; and was shown, that the effect had not been due to mechanical compression.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
ronicol

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
600 mg 2 times / day steady, oral
Recommended
Dose: 600 mg, 2 times / day
Route: oral
Route: steady
Dose: 600 mg, 2 times / day
Sources:
unhealthy, 30 - 66 years
n = 20
Health Status: unhealthy
Condition: hyperlipoproteinemia
Age Group: 30 - 66 years
Sex: M+F
Population Size: 20
Sources:
Other AEs: Increased appetite, Skin rash...
Other AEs:
Increased appetite (15%)
Skin rash (36%)
Itching (37%)
Flushing (68%)
Nausea (50%)
Abdominal pain (15%)
Sources:
AEs

AEs

AESignificanceDosePopulation
Abdominal pain 15%
600 mg 2 times / day steady, oral
Recommended
Dose: 600 mg, 2 times / day
Route: oral
Route: steady
Dose: 600 mg, 2 times / day
Sources:
unhealthy, 30 - 66 years
n = 20
Health Status: unhealthy
Condition: hyperlipoproteinemia
Age Group: 30 - 66 years
Sex: M+F
Population Size: 20
Sources:
Increased appetite 15%
600 mg 2 times / day steady, oral
Recommended
Dose: 600 mg, 2 times / day
Route: oral
Route: steady
Dose: 600 mg, 2 times / day
Sources:
unhealthy, 30 - 66 years
n = 20
Health Status: unhealthy
Condition: hyperlipoproteinemia
Age Group: 30 - 66 years
Sex: M+F
Population Size: 20
Sources:
Skin rash 36%
600 mg 2 times / day steady, oral
Recommended
Dose: 600 mg, 2 times / day
Route: oral
Route: steady
Dose: 600 mg, 2 times / day
Sources:
unhealthy, 30 - 66 years
n = 20
Health Status: unhealthy
Condition: hyperlipoproteinemia
Age Group: 30 - 66 years
Sex: M+F
Population Size: 20
Sources:
Itching 37%
600 mg 2 times / day steady, oral
Recommended
Dose: 600 mg, 2 times / day
Route: oral
Route: steady
Dose: 600 mg, 2 times / day
Sources:
unhealthy, 30 - 66 years
n = 20
Health Status: unhealthy
Condition: hyperlipoproteinemia
Age Group: 30 - 66 years
Sex: M+F
Population Size: 20
Sources:
Nausea 50%
600 mg 2 times / day steady, oral
Recommended
Dose: 600 mg, 2 times / day
Route: oral
Route: steady
Dose: 600 mg, 2 times / day
Sources:
unhealthy, 30 - 66 years
n = 20
Health Status: unhealthy
Condition: hyperlipoproteinemia
Age Group: 30 - 66 years
Sex: M+F
Population Size: 20
Sources:
Flushing 68%
600 mg 2 times / day steady, oral
Recommended
Dose: 600 mg, 2 times / day
Route: oral
Route: steady
Dose: 600 mg, 2 times / day
Sources:
unhealthy, 30 - 66 years
n = 20
Health Status: unhealthy
Condition: hyperlipoproteinemia
Age Group: 30 - 66 years
Sex: M+F
Population Size: 20
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Picolinyl ester fragmentation mechanism studies with application to the identification of acylcarnitine acyl groups following transesterification.
2006 Nov
Enzymatic oxidation of NADP+ to its 4-oxo derivative is a side-reaction displayed only by the adrenodoxin reductase type of ferredoxin-NADP+ reductases.
2007 Aug
Copper (II) complexes of the anti-inflammatory drug naproxen and 3-pyridylmethanol as auxiliary ligand. Characterization, superoxide dismutase and catecholase--mimetic activities.
2010 Sep
Patents

Sample Use Guides

25 mg tablet 4 times a daily
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
NICOTINYL ALCOHOL
INCI   MART.   MI   USAN   WHO-DD  
USAN   INCI  
Official Name English
C10AD05
Code English
Nicotinyl alcohol [WHO-DD]
Common Name English
PYRIDYLMETHANOL
Systematic Name English
RO-1-5155
Code English
NSC-526046
Code English
RO-15155
Code English
NICOTINYL ALCOHOL [MART.]
Common Name English
NICOTINIC ALCOHOL
Common Name English
NU-2121
Code English
RO 1-5155
Code English
3-HYDROXYMETHYLPYRIDINE
Systematic Name English
NICOTINYL ALCOHOL [INCI]
Common Name English
NICOTINYL ALCOHOL [USAN]
Common Name English
.BETA.-PYRIDYLCARBINOL
Common Name English
NICOTINYL ALCOHOL [MI]
Common Name English
3-Pyridinemethanol
Systematic Name English
PYRIDYLCARBINOL
Systematic Name English
Classification Tree Code System Code
WHO-ATC C10AD05
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
WHO-ATC C04AC02
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
NCI_THESAURUS C29707
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
WHO-VATC QC04AC02
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
WHO-VATC QC10AD05
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
Code System Code Type Description
NSC
526046
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
CHEBI
45213
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
WIKIPEDIA
NICOTINYL ALCOHOL
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
FDA UNII
9TF312056Y
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
RXCUI
7414
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY RxNorm
MERCK INDEX
m7882
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY Merck Index
SMS_ID
100000079994
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
ChEMBL
CHEMBL1235535
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
MESH
D009540
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
NCI_THESAURUS
C61860
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
PUBCHEM
7510
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
CAS
100-55-0
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
EPA CompTox
DTXSID6023367
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
DRUG CENTRAL
1921
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
EVMPD
SUB14650MIG
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
ECHA (EC/EINECS)
202-864-6
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY
DRUG BANK
DB04145
Created by admin on Fri Dec 15 15:22:11 GMT 2023 , Edited by admin on Fri Dec 15 15:22:11 GMT 2023
PRIMARY